Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages.
about
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signalingElectronegative LDL: a circulating modified LDL with a role in inflammationNew covalent modifications of phosphatidylethanolamine by alkanals: mass spectrometry based structural characterization and biological effects.Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation.Allicin prevents oxidized low-density lipoprotein-induced endothelial cell injury by inhibiting apoptosis and oxidative stress pathwayTLR2 expression doesn't change in ox-LDL mediated inflammation in Human umbilical vein endothelial cells under high glucose cultureEffects of Porphyromonas gingivalis lipopolysaccharide on the expression of key genes involved in cholesterol metabolism in macrophages.Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.Signaling events in pathogen-induced macrophage foam cell formation.The danger model: questioning an unconvincing theory.Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage.Effect of Melilotus extract on lung injury via the upregulation of tumor necrosis factor-α-induced protein-8-like 2 in septic mice.Role of MyD88-dependent and MyD88-independent signaling in Porphyromonas gingivalis-elicited macrophage foam cell formation.The class A scavenger receptor SR-A/CD204 and the class B scavenger receptor CD36 regulate immune functions of macrophages differently.Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease.Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease.
P2860
Q26866939-19167A90-CA58-43CC-B373-C8F2853E15EDQ27015769-E94EFDE7-9499-48B3-8194-D2B03C2D92DDQ34392320-438CDDF2-9037-4143-B5E4-08AEF6C459D4Q35061594-C865A53E-0B58-4100-9B0F-B506E4CCD031Q36024749-643C3103-F298-4F10-BACE-EF80F7A3BEC4Q36493416-112BF3A1-AEAB-4F0C-8450-67365C5DE17BQ37243045-6E07B20C-7BC6-4872-AFAB-BBC0E9629C52Q37499216-0729F307-AAB8-4271-9E59-6A19C0D9CE62Q37835915-A61496AC-2DE2-4DAA-9A3E-CD1F9EC0855BQ38555406-8A92F8E7-A638-4F25-884F-8E5DC13B330DQ38971397-BADDF4F9-95F9-4D1B-9D13-57CF05D72256Q41657284-5E5FC8E6-05E0-4826-875F-16F7C2644A5BQ41894655-621F819E-E291-43EF-8711-061F2E987002Q43592532-7695DE12-F03D-4D93-93B6-9361310A232FQ51538107-20BACD20-A932-4FF5-999D-3BB25D17200CQ54899454-1378754A-5593-41E4-98EE-D5D2D91850E4
P2860
Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oxidatively modified low densi ...... ocytes but not in macrophages.
@ast
Oxidatively modified low densi ...... ocytes but not in macrophages.
@en
type
label
Oxidatively modified low densi ...... ocytes but not in macrophages.
@ast
Oxidatively modified low densi ...... ocytes but not in macrophages.
@en
prefLabel
Oxidatively modified low densi ...... ocytes but not in macrophages.
@ast
Oxidatively modified low densi ...... ocytes but not in macrophages.
@en
P2093
P2860
P356
P1476
Oxidatively modified low densi ...... ocytes but not in macrophages.
@en
P2093
Chandrakala Aluganti Narasimhulu
Kruthika Sundaram
Mark D Wewers
Sampath Parthasarathy
Yashaswini Kannan
P2860
P304
23479-23488
P356
10.1074/JBC.M111.320960
P407
P577
2012-05-21T00:00:00Z